Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2007
12/04/2007US7304037 Cytostatic conjugates with integrin ligands
12/04/2007US7304033 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules
12/04/2007US7304032 CD-10 activated prodrug compounds
12/04/2007US7303926 Causing necrosis or apoptosis of target tissue using both type 1 and type 2 mechanisms
12/04/2007US7303911 Useful as vaccine for the treatment of prostate cancer especially with a vaccine adjuvant which may include Il-2, IL-12, interferon gamma, BCG, tetanus toxoid or Mycobacterium Vaccae.
12/04/2007US7303889 Ligand for G-protein coupled receptor GPR43 and uses thereof
12/04/2007US7303885 For treating or detecting MIF (macrophage migration inhibitor factor) related diseases by detecting MIF/Jab1 (c-Jun activation domain binding protein) interactions; complex MIF in natural association with Jab1 and optionally another protein
12/04/2007US7303739 Cyclic phosph(oramid)ate prodrugs having alcohol, amine, orthiol groups attached to phosphorus; camptothecins; pharmacodynamic half-life; diagnostic imaging
12/04/2007CA2427856C The composition of multipurpose high functional alkaline solution composition, preparation thereof, and for the use of nonspecific immunostimulator
12/04/2007CA2321826C Pharmaceutical formulations of taxanes
12/04/2007CA2310677C In vitro and in vivo growth-promoting proteins and peptides for kidney epithelial cells
12/04/2007CA2283295C Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels
12/04/2007CA2255891C Compositions and methods for treating or preventing diseases of body passageways
12/04/2007CA2212205C Use of xanthine derivatives for the modulation of apoptosis
12/04/2007CA2210533C Imidazole derivatives, their preparation and their use as s-adenosylmethionine decarboxylase (=samdc) inhibitors
11/2007
11/29/2007WO2007137130A1 Magnetorheological fluids and therapeutic uses thereof
11/29/2007WO2007137000A2 Combination cancer chemotherapy
11/29/2007WO2007136692A2 Crystalline forms of 5-chloro-6- (2, 6-difluoro-4- [3- (methylamino) propoxy] phenyl)-n-((1s)-2, 2, 2,-trifluoro-1-methylethyl] [1,2,4] triazolo [1,5-a] pyrimidin-7-amine salts
11/29/2007WO2007136650A2 Method and compositions for treating hematological malignancies
11/29/2007WO2007136510A2 Polymorphic forms of imatinib mesylate and processes for their preparation as well as of amorphous imatinib mesylate and form alpha
11/29/2007WO2007136107A1 Method of constructing gene transport support
11/29/2007WO2007136103A1 Antitumor agent for thyroid cancer
11/29/2007WO2007135910A1 Polymer conjugate of podophyllotoxin
11/29/2007WO2007135781A1 Peptide capable of enhancing the activity of ephrin-b2, salt thereof, composition for medical purposes, kit for therapy
11/29/2007WO2007135766A1 Ointment for amelioration or treatment of oral tumor
11/29/2007WO2007135592A1 Flavonoid dimers and methods of making and using such
11/29/2007WO2007135411A1 39-desmethoxy-39-methyl derivatives of rapamycin.
11/29/2007WO2007135410A1 Ruthenium ii compounds
11/29/2007WO2007135397A1 36 -des (3 -methoxy-4 -hydroxycyclohexyl) 36 - (3 -hydroxycycloheptyl) derivatives of rapamycin for the treatment of cancer and other disorders
11/29/2007WO2007135295A2 Derivatives of 2-alkoxy-3,4,5-trihydroxy-alkyl amides, preparation and use thereof, and compositions containing the same
11/29/2007WO2007135293A2 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzazepines, the preparation and use thereof, and compositions containing the same
11/29/2007WO2007135284A1 Use of cells derived from adipose tissue for the preparation of an anti-tumour medicament
11/29/2007WO2007135095A1 Use of cis-rhenium (iii) diadamantate compounds for potentiating the antitumoral activity of platinium complexes
11/29/2007WO2007135027A1 Substituted pteridines substituted with a four-membered heterocycle
11/29/2007WO2007134678A2 Triazole derivatives ii
11/29/2007WO2007134677A1 1,5-diphenylpyrazoles ii as hsp90 inhibitors
11/29/2007WO2007134595A2 Novel formulation, oriented to tumour physiology, of a cytostatic, in particular of cis-platinum
11/29/2007WO2007134578A1 Novel indol-pyrrol derivatives for the treatment of proliferative and inflammatory diseases
11/29/2007WO2007134538A1 Rat antihuman macrophage migration inhibitory factor monoclonal antibody and its application
11/29/2007WO2007134534A1 WATER SOLUTION OF 20(R)-GINSENOSIDE Rg3 PHARMACEUTICAL COMPOSITION AND PROCESS THEREOF
11/29/2007WO2007134533A1 20(R)-GINSENOSIDE Rg3 MEDICINAL SOLUBLE INTERMEDIATE AND PROCESS THEREOF
11/29/2007WO2007134354A1 Pharmaceutical formulation
11/29/2007WO2007120760A3 Thiophene-carboxamides useful as inhibitors of protein kinases
11/29/2007WO2007117563A3 1.alpha.-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin d compounds and methods of making and use thereof
11/29/2007WO2007115620A3 Novel cyclobutyl compounds as kinase inhibitors
11/29/2007WO2007113269A3 15-desmethoxymacbecin derivatives for the treatment of cancer diseases
11/29/2007WO2007113249A3 N-hydroxy-3-(4-{3-phenyl-s-oxo-propenyl}-phenyl)-acrylamide derivatives and related compounds as histone deacetylase inhibitors for the treatment of cancer
11/29/2007WO2007112914A3 Ceramide kinase modulation
11/29/2007WO2007110705A3 Macrolide as inhibitors of mhc class ii
11/29/2007WO2007110210A3 Angiomotin sirna molecules and uses thereof
11/29/2007WO2007088460A3 Tgf-beta modulators and use thereof
11/29/2007WO2007085629A3 Use of hyaluronic acid as a carrier molecule for?different classes of therapeutic active agents
11/29/2007WO2007080392A3 Ligands that have binding specificity for vegf and/or egfr and methods of use therefor
11/29/2007WO2007067992A3 Human monoclonal antibodies to fucosyl-gm1 and methods for using anti-fucosyl-gm1
11/29/2007WO2007064753A3 Cancer treatment method
11/29/2007WO2007059341A3 Pyrazolothiazole protein kinase modulators
11/29/2007WO2007042241A3 Selective alfavbeta3 receptor peptide antagonist for therapeutic and diagnostic applications
11/29/2007WO2007017144A3 Macrocylic inhibitors of hepatitis c virus
11/29/2007WO2006095159A8 (imidazolo-5-yl)-2-anilo-pyrimidines as agents for the inhibition of cell proliferation
11/29/2007WO2006079539A3 Use of pyrimidylaminobenzamides for the treatment of diseases that respond to modulation of tie-2 kinase activity
11/29/2007WO2002028345A3 Aldehyde-releasing compounds
11/29/2007US20070276147 Synthesis of Oligomeric Epicatechin- and Catechin-Derived Procyanidins
11/29/2007US20070276043 3-(p-Substituted alkoxyphenyl)-2-(o-benzoylanilino)propionic acid derivatives, e.g., 2-(o-Benzoylphenylamino)-3-(p-{2-[(o-fluorophenyl)isobutylamino]-ethoxy}phenyl)propionic acid; for treating non-insulin dependent diabetes and obesity
11/29/2007US20070276039 Pharmaceutical uses for alpha2delta ligands
11/29/2007US20070276017 Thiadiazoline Derivative
11/29/2007US20070276016 Cholecystokinin (CCK2) receptor modulators; e.g. 2-(Benzo[1,2,5]thiadiazole-4sulfonylamino)-4-fluoro-N-[1-(4-fluoro-phenyl)-ethyl]-N-methyl-benzamide; pancreatic adenocarcinoma, pain, eating disorders, gastro-esophageal reflux disease, ulcers, anxiety
11/29/2007US20070276015 Crystal modification of torasemide
11/29/2007US20070276011 Plasminogen Activator Inhibitor-1 Inhibitor
11/29/2007US20070275991 Drug Delivery From Embolic Agents
11/29/2007US20070275983 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
11/29/2007US20070275972 Pyridopyrazines and the use thereof as kinase inhibitors
11/29/2007US20070275965 CXCR4 modulators
11/29/2007US20070275961 Triazolo ' 1, 5-A ! Pyrimidines and Their Use in Medicine
11/29/2007US20070275954 Novel Fused Heterocycles and Uses Thereof
11/29/2007US20070275952 Tie-2 Modulators and Methods of Use
11/29/2007US20070275942 Compositions and Uses of Et 743 for Treating Cancer
11/29/2007US20070275936 Formulations and Treatment Methods
11/29/2007US20070275917 Rna Capable of Suppressing Expression of Klf5 Gene
11/29/2007US20070275915 Tmprss2 Regulatory Sequences and Uses Thereof
11/29/2007US20070275910 Phosphoramidate Derivatives
11/29/2007US20070275903 oligopeptide conjugates; cleavable by trouase such as Thimet oligopeptidase; antitumor agents
11/29/2007US20070275902 Treatment of Phosphatidylinositol Phospholipid Disorders
11/29/2007US20070275895 Inhibiting proliferation of immune cells in leukemia comprising administering an antibody that specifically binds a follistatin-3 polypeptide; inhibiting B cell or T cell proliferation
11/29/2007US20070275440 Regulation of transcription factor, nf-il6/lap
11/29/2007US20070275106 Hydroxylated polymethoxyflavone compositions
11/29/2007US20070275001 Rational Design and Engineering of Proteins and Peptides for Immunomodulation
11/29/2007US20070274998 Novel Bispecific Molecules For Use In Therapy And Diagnosis
11/29/2007US20070274996 IL-4R antagonists; allergies and asthma
11/29/2007US20070274990 Novel Therapeutic Targets in Cancer
11/29/2007US20070274988 Kiaa0779, Splice Variants Thereof, and Methods of Their Use
11/29/2007US20070274982 Anti-EpCam Immunoglobulins
11/29/2007US20070274974 Compositions and methods for restoring immune responsiveness in patients with immunological defects
11/29/2007US20070274971 Method of Proliferating Precursor Cells
11/29/2007US20070274953 Photochemical internalization for delivery of molecules into the cytosol
11/29/2007US20070274952 Compositions and Methods for Modifying the Content of Polyunsaturated Fatty Acids in Biological Cells
11/29/2007US20070274948 Methods of Therapy for Chronic Lymphocytic Leukemia
11/29/2007US20070274947 Antisense Oligonucleotides Directed to Ribonucleotide Reductase R1 and Uses Thereof in the Treatment of Cancer
11/29/2007US20070274909 Radiation Therapy and Medical Imaging Using Uv Emitting Nanoparticles
11/29/2007US20070274908 Methods and compositions related to adenoassociated virus-phage particles
11/29/2007DE68907430C5 Cytotoxische Therapie. Cytotoxic therapy.
1 ... 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 ... 2211